Chartwell Investment Partners’s Viking Therapeutics VKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
$2.32M Buy
36,666
+17,159
+88% +$1.09M 0.08% 276
2024
Q2
$1.04M Sell
19,507
-12,056
-38% -$640K 0.04% 345
2024
Q1
$2.59M Sell
31,563
-22,906
-42% -$1.88M 0.09% 264
2023
Q4
$1.01M Sell
54,469
-7,350
-12% -$137K 0.04% 354
2023
Q3
$685K Hold
61,819
0.03% 376
2023
Q2
$1M Buy
61,819
+10,491
+20% +$170K 0.04% 353
2023
Q1
$854K Sell
51,328
-36,514
-42% -$608K 0.03% 357
2022
Q4
$826K Buy
+87,842
New +$826K 0.03% 360